Cancer
Researchers from Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital have recently conducted a study on the efficacy and safety of combining adebrelimab with apatinib and irinotecan for advanced gastric cancer refractory to PD-1 inhibitors. The single-arm, single-centre exploratory trial aimed to evaluate the combination therapy's
Cancer
Scientists at Bengbu Med Univ have made groundbreaking advancements in biotechnology, specifically in the field of cancer gene therapy. By leveraging cutting-edge nanotechnology, researchers have developed sophisticated nanomaterials that accurately control and target nitric oxide (NO) delivery, overcoming its inherent limitations. This innovative approach has shown significant promise in treating
Cancer
Researchers at the Shanghai University of Traditional Chinese Medicine have made a significant advancement in cancer therapy by developing artificial NK-EVs, which demonstrate superior scalability and bioactivity compared to natural EVs. According to the study, these artificial EVs can induce 70% cytotoxicity in lung cancer cells, trigger apoptosis, and restore
Cancer
Pembrolizumab, a PD-1 inhibitor, has shown potential in increasing tumor-infiltrating lymphocytes and promoting local tumor immunologic recruitment, according to a pilot study published in Gynecologic Oncology Reports. The study, conducted by researchers at the Duke Cancer Institute, assessed the feasibility, toxicity, and changes in immune parameters in response to one
Cancer
Researchers from Liaoning Cancer Hospital and Institute have made a groundbreaking discovery in the field of immunotherapy, developing a novel artificial intelligence (AI) model that accurately predicts pathological response to neoadjuvant chemo-immunotherapy in non-small-cell lung cancer (NSCLC). The study, published in the Journal for ImmunoTherapy of Cancer, utilized a retrospective
Cancer
The Uganda Cancer Institute's Center for Natural Therapeutics (CENAT) has developed seven herbal products with potential to prevent cancer, shrink tumors, and alleviate the side effects of conventional treatment. The products, still under investigation, have shown promising early results and will undergo clinical trials. CENAT aims to provide
Cancer
Prestige Flowers, a leading UK-based online florist, has launched a new bouquet, "The Race for Life", in partnership with Cancer Research UK. The arrangement features gorgeous Memory Lane roses alongside pink snapdragons, chrysanthemums, and lisianthus, making it the perfect way to show support for the annual fundraising event.
Cancer
Researchers from China Jiliang University have made significant progress in cancer immunotherapy by identifying neoantigens as key targets for eliminating cancer cells. According to a recent study published in the International Journal of Oncology, neoantigens are abnormal peptide fragments or protein segments uniquely expressed in tumor cells, making them highly
Cancer
Researchers at Saveetha Engineering College have made a significant breakthrough in malaria detection by developing a metasurface biosensor that can simultaneously detect cancer and malaria biomarkers. This innovative device operates at frequencies between 0.189-0.423 THz and demonstrates exceptional sensitivity for both cancer and malaria detection. The sensor'
Cancer
Cancer Weekly has released a report on the latest advancements in cancer gene therapy, focusing on the potential of Chimeric Antigen Receptors (CARs) presented by Natural Killer (NK) cells. Researchers from Aix-Marseille University have made significant strides in the field, allowing for the targeting of cell-surface expressed molecules in an
Cancer
Researchers at Lanzhou University have made significant progress in identifying potential biomarkers for early gastric cancer diagnosis. Through a machine learning-based approach, the team identified several genes associated with immune cell infiltration in the tumor microenvironment. The new biomarkers, including TAGLN2, HSP90AB1, SH3BGRL3, and CFL1, demonstrated strong diagnostic performance and
Cancer
Researchers at the Affiliated Hospital of Qingdao University have made a breakthrough in understanding the potential therapeutic strategy for treating gastric cancer. According to the study published in Frontiers in Cell and Developmental Biology, perillaldehyde (PAH) has been shown to inhibit tumor growth in gastric cancer cells through multiple mechanisms.
